Solvay SA Says Mulling Options For Drugs Unit

April 1, 2009 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

AMSTERDAM, April 1 (Reuters) - Belgian drugs, chemicals and plastics maker Solvay (SOLB.BR) said on Wednesday it is analysing various options for its pharmaceutical activities and may enter talks with various third parties about the business.

Twitter
LinkedIn
Facebook
Email
Print

Mergers & acquisitions Europe